Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study
ConclusionThe FHR found in the SR NDMM patient group has unique clinical features, including being male, with EMD and CPC, and genetic characteristics of mutations affecting oxidative stress, chromosome segregation, and hypoxia tolerance. In contrast to previous reports, our data suggested that patients with P53 mono-allelic inactivation should be classified in the GHR group rather than the FHR group. (Source: Frontiers in Oncology)
Source: Frontiers in Oncology - March 10, 2023 Category: Cancer & Oncology Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas
CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576 (Source: Technology and Health Care)
Source: Technology and Health Care - March 6, 2023 Category: Medical Devices Authors: Qiu-Si Tian Qun Zhang Wei Huang Source Type: research
